Belviq

Practice Areas > Pharmaceutical Liability > Belviq

If you or a loved one has been diagnosed with cancer after using the weight loss drug, Belviq, we urge you to contact our pharmaceutical liability attorneys by calling 1.800.556.5522 or by filling out the form below. 

 

Belviq
For how long did you or a loved one take Belviq or Belviq XR? *
Are you or a loved one still taking Belviq? *
First
Last
Address *
Address
Street Address 1
Street Address 2
City
State/Province
Zip/Postal
Country

At this time, we are only reviewing cases of those who were prescribed this medication. Thank you for your inquiry

Please provide us additional information about your Belviq use

Have you or a family member been diagnosed with: *
Did you or a family member take Belviq for at least one year prior to a cancer diagnosis? *
Are you or a family member still taking Belviq? *

What is Belviq?

Belviq, also known as lorcaserin, is a weight-loss drug that affects the signals in the brain that control appetite. Generally, this medication is used to treat obesity along with a change in diet in exercise in the consumers it is prescribed to. Belviq is strictly used to control appetite and does not work to control any other underlying health condition. Originally approved in 2012 by the FDA, the drug manufacturer was required to conduct a clinical trial evaluating potential cardiovascular problems. However, after this clinical trial was completed, an increased risk of cancer, specifically pancreatic, colorectal and lung cancer. 7.7% of patients who took Belviq were diagnosed with cancer, compared to 7.1% in a comparison given dummy pills.

Warning Issued for Patients and Healthcare Professionals

After the FDA sent their request to Eisai Inc., a warning was issued about the potential risks associated with both Belviq and Belviq XR. In this warning, the FDA asks that professionals evaluate the potential risks and benefits of prescribing Belviq to their patients, and understand the increased likelihood of cancer diagnosis. Additionally, the FDA has been advising patients who are already in possession of Belviq or Belviq XR tablets to dispose of them safely, such as a designated drug take-back location. While the FDA is not asking that healthcare professionals issue additional screenings for cancer, it is vital for both the doctor and patient to monitor any adverse effects of Belviq and consider alternative methods for weight loss.

Contact the Pharmaceutical Liability Attorneys at The Law Offices of Peter Angelos Today. 

When manufacturers release a product that can bring potential harm to consumers, you deserve to have an advocate on your side to help you through this trying process, such as a qualified pharmaceutical liability attorney at Peter Angelos, P.C. If you or a loved one has been adversely affected by Belviq or Belviq XR, schedule a free consultation with the Law Offices of Peter Angelos P.C. today.